Skip Navigation



JAC Advance Access published online on September 12, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki292
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/5/948    most recent
dki292v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cagliero, C.
Right arrow Articles by Cloeckaert, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cagliero, C.
Right arrow Articles by Cloeckaert, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2005
Received June 6, 2005
Revised July 26, 2005
Accepted July 27, 2005

Brief report

Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli

Cédric Cagliero 1, Christian Mouline 1, Sophie Payot 1*, and Axel Cloeckaert 1

1 Institut National de la Recherche Agronomique, UR086 BioAgresseurs, Santé, Environnement, 37380 Nouzilly, France

* To whom correspondence should be addressed.
Sophie Payot, E-mail: payot{at}tours.inra.fr


  Abstract

Objectives: This study was conducted to examine the role of the CmeABC efflux pump in decreasing the susceptibility of Campylobacter coli to macrolides and ketolides in the context of absence or presence of mutations in the 23S rRNA genes.

Methods: The cmeB gene was inactivated in strains of C. coli showing two different patterns of erythromycin resistance (low or high level of resistance) associated with the absence or presence of a A2075G mutation in the 23S rRNA genes. MICs of erythromycin, azithromycin, tylosin, telithromycin and ciprofloxacin were compared for wild-type (with or without efflux pump inhibitor) and mutant strains.

Results: The cmeB gene inactivation (or addition of efflux pump inhibitor) led to the restoration of susceptibility of the low-level-resistant strains (no A2075G mutation in the 23S rRNA genes). In the highly resistant strains (A2075G mutation in the 23S rRNA genes), the MICs of erythromycin decreased 128- to 512-fold upon inactivation of the cmeB gene. MICs of azithromycin, tylosin and telithromycin were also affected by both addition of efflux pump inhibitor and cmeB gene inactivation, revealing these molecules as substrates of the CmeABC efflux pump. Compared with azithromycin, MICs of telithromycin drastically decreased upon cmeB gene inactivation even in the presence of a A2075G mutation in 23S rRNA genes.

Conclusions: The CmeABC efflux pump acts synergically with 23S rRNA mutations to drastically increase the MICs of erythromycin and tylosin in C. coli. In contrast, azithromycin was less affected by efflux and telithromycin, although being a good substrate for the CmeABC efflux pump, was less affected by an A2075G mutation in 23S rRNA genes.

Keywords: transporters; gene inactivation; mutations; 23S rRNA; ketolides.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
D. Fange, K. Nilsson, T. Tenson, and M. Ehrenberg
Drug efflux pump deficiency and drug target resistance masking in growing bacteria
PNAS, May 19, 2009; 106(20): 8215 - 8220.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
M. Haas, A. Essig, E. Bartelt, and S. Poppert
Detection of Resistance to Macrolides in Thermotolerant Campylobacter Species by Fluorescence In Situ Hybridization
J. Clin. Microbiol., November 1, 2008; 46(11): 3842 - 3844.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
M. Hannula and M.-L. Hanninen
Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli
J. Med. Microbiol., July 1, 2008; 57(7): 851 - 855.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Gibreel, N. M. Wetsch, and D. E. Taylor
Contribution of the CmeABC Efflux Pump to Macrolide and Tetracycline Resistance in Campylobacter jejuni
Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3212 - 3216.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
T. Quinn, J.-M. Bolla, J.-M. Pages, and S. Fanning
Antibiotic-resistant Campylobacter: could efflux pump inhibitors control infection?
J. Antimicrob. Chemother., June 1, 2007; 59(6): 1230 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. Lin, M. Yan, O. Sahin, S. Pereira, Y.-J. Chang, and Q. Zhang
Effect of Macrolide Usage on Emergence of Erythromycin-Resistant Campylobacter Isolates in Chickens
Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1678 - 1686.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. Lin and A. Martinez
Effect of efflux pump inhibitors on bile resistance and in vivo colonization of Campylobacter jejuni
J. Antimicrob. Chemother., November 1, 2006; 58(5): 966 - 972.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. Cagliero, C. Mouline, A. Cloeckaert, and S. Payot
Synergy between Efflux Pump CmeABC and Modifications in Ribosomal Proteins L4 and L22 in Conferring Macrolide Resistance in Campylobacter jejuni and Campylobacter coli
Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3893 - 3896.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
A. Gibreel and D. E. Taylor
Macrolide resistance in Campylobacter jejuni and Campylobacter coli
J. Antimicrob. Chemother., August 1, 2006; 58(2): 243 - 255.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.